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Abstract
Background: Several techniques have been described for the management of fistula-in-ano, but all carry their own
risks of recurrence and incontinence. We conducted a prospective study to assess type of presentation, treatment
strategy and outcome over a 5-year period.
Methods: Between 1st January 2005 and 31st March 2011 247 patients presenting with anal fistulas were treated
at the University Hospital Tor Vergata and were included in the present prospective study. Mean age was 47 years
(range 16-76 years); minimum follow-up period was 6 months (mean 40, range 6-74 months).
Patients were treated using 4 operative approaches: fistulotomy, fistulectomy, seton placement and rectal
advancement flap. Data analyzed included: age, gender, type of fistula, operative intervention, healing rate,
postoperative complications, reinterventions and recurrence.
Results: Etiologies of fistulas were cryptoglandular (n = 218), Crohn’s disease (n = 26) and Ulcerative Colitis (n = 3).
Fistulae were classified as simple -intersphincteric 57 (23%), low transphincteric 28 (11%) and complex -high
transphicteric 122 (49%), suprasphincteric 2 (0.8%), extrasphinteric 2 (0.8%), recto-vaginal 7 (2.8%) Crohn 26 (10%)
and UC 3 (1.2%).
The most common surgical procedure was the placement of seton (62%), usually applied in case of complex
fistulae and Crohn’s patients.
Eighty-five patients (34%) underwent fistulotomy, mainly for intersphincteric and mid/low transphincteric tracts.
Crohn’s patients were submitted to placement of one or more loose setons.
The main treatment successfully eradicated the primary fistula tract in 151/247 patients (61%). Three cases of
major incontinence (1.3%) were detected during the follow-up period; Furthermore, three patients complained
minor incontinence that was successfully treated by biofeedback and permacol injection into the internal anal
sphincter.
Conclusions: This prospective audit demonstrates an high proportion of complex anal fistulae treated by seton
placement that was the most common surgical technique adopted to treat our patients as a first line. Nevertheless,
a good outcome was achieved in the majority of patients with a limited rate of faecal incontinence (6/247 = 2.4%).
New technologies provide promising alternatives to traditional methods of management particularly in case of
complex fistulas. There is, however, a real need for high-quality randomized control trials to evaluate the different
surgical and non surgical treatment options.
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Anal fistula represents an important aspect of colorectal
practice, being a distressing condition for the patient
and sometimes a challenge for the surgeon.
The majority of anal fistulae are of crypto-glandular
origin, following anorectal abscess in 7-40% of cases [1].
Besides, anal fistulae are sometimes associated to other
conditions, mainly inflammatory bowel disease, particu-
larly Crohn’s disease.
According to the cryptoglandular hypothesis, intersphin-
teric gland infection is the initiating event in the formation
of perianal fistulas [2]. The sepsis arising within these
glands can spread into the inter-sphincteric space, and
from here towards the different anorectal planes causing
abscesses and fistulae. Parks suggested the most widely
used classification of intersphincteric, transphincteric,
suprasphincteric, and extrasphincteric fistulas [3].
The targets of surgical management are sepsis drai-
nage and fistula tracts removal, preserving sphincter
integrity whenever possible and avoiding recurrence of
sepsis.
A high success rate is generally reported in literature
for low transphincteric fistulas involving the lower 3
rd of
the external anal sphincter [4].
Besides, the treatment of complex anal fistulas is still a
challenge for the colorectal surgeon with variable success
rate reported in different trials [4,5].
Surgical procedures for high transphincteric fistulas
include advancement flap closure, with a different suc-
cess rate according to the etiology of the fistula [6-8] and
a recurrence rate ranging between 0% and 63%. Cutting
setons have been used in an attempt to slowly divide the
sphincters while allowing scarring to occur and limit dis-
ruption of the muscular ring, with recurrence rates from
22% to 39% [9,10]. During the last ten years, fibrin glue
injection has become a popular alternative to the cutting
seton and mucosal advancement flap repair of complex
fistulas; however, the published success rates widely
between 14% and 60% [11-13].
The aim of the present study was to assess prospec-
tively the presentation, classification, management and
outcome of a series of 247 consecutive patients present-
ing with fistula-in-ano at our institution in a 5-year
period.
Methods
Between January 2005 and March 2011, 247 patients
underwent Examination Under Anaesthesia (EUA) for
fistula-in-ano at our Institution and were included in
this prospective study.
All patients were examined by a colorectal surgeon in
the outpatients clinic; the pre-treatment evaluation
included anamnesis, concerning pregnancies, episiotomy,
previous gynaecological, urological, or ano-rectal surgery
and symptoms, clinical examination of the perineum and
anorectum and proctoscopy.
The Wexner continence score and the FISI score were
adopted to evaluate the degree of continence in every
patient.
Colonoscopy, anorectal manometry, magnetic reso-
nance and/or endoanal ultrasonography were performed
if necessary, particularly in patients with diagnosis of
inflammatory bowel disease.
Fistulae were classified on the basis of operative find-
ings according to Parks’ classification. Written informed
consent had been obtained from all the subjects after a
full explanation of the procedure. All surgical proce-
dures were performed by four certified colorectal sur-
geons (PS, GM, FC, LF).
Surgery was performed with the patient in lithotomy
position under local anaesthesia in most cases and, if
necessary, general anaesthesia was provided. The stan-
dard preoperative protocol included a phosphate enema
performed 12 hours before surgery and 500 mg of
metronidazole plus 2 gr of cefotaxime given intrave-
nously at the beginning of surgery.
After the discharge, patients were assessed at the first
follow up visit after 7 days; further controls were sched-
uled at 1, 3 and 6 months. Additional controls were per-
formed to manage the cutting setons. Thereafter phone
interviews were performed annually.
All the data concerning baseline characteristics of
patients, details of presentation, fistula etiology and
anatomy, surgery performed and surgical outcomes were
analyzed.
During the follow up period details of wound healing,
postoperative complications (bleeding, nausea, vomiting,
urinary dysfunction) and time of resumption of work,
were recorded; late complications such as fistula recur-
rences, flatus or liquid incontinence, reinterventions
were also assessed.
Results
Between January 2005 and March 2011, 247 patients pre-
sented with anal fistula and were treated at the Depart-
ment of Surgery, Tor Vergata University Hospital, Rome.
One hundred forty-nine were males and 98 females;
mean age was 47 years (range 16-76 years). Mean fol-
low-up period after surgery was 40 months (range 6-74
months).
The fistula was idiopathic in 218 patients (88%) and
associated to inflammatory bowel disease (IBD) in 29
patients (11%), of which 26 associated to Crohn’s disease
(CD) and 3 to Ulcerative Colitis (UC).
Mean duration of symptoms before surgery was 18
months.
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122 (52.8%) and, among them,77 (33.3%) underwent
surgical drainage, and 45 (19.4%) drained spontaneously.
Twenty-seven patients underwent previous surgery for
anal fistula in other hospitals prior to referral to our
department. Fourteen patents had an history of previous
anorectal surgery: haemorroidectomy (9 patients), lateral
internal sphincterotomy (1), sphincteroplasty (1), Block
repair of anterior rectocele (1), ileo-anal pouch (1), anal
polyp excision (1).
Fifteen patients presented with proctological comorbi-
dites: anal fissure (six patients), anal polyps (3), haemor-
rhoids (2), haemorrhoids plus polyps (2), fissure plus
polyps (1) and anal condylomatosis (1). Patient with
polyps and condilomatosis were treated at the same
surgery.
On clinical examination, fifty-seven (23%) were inter-
sphincteric, one hundred and fifty (60%) transphincteric,
2 (0.8%) suprasphincteric, 2 (0.8%) extrasphinteric,
7 (2.8%) recto-vaginal fistulas.
Five patients presented two or more fistula tracts and
further three patients presented with multiple fistula
tracts associated to abscess. In two cases a recto-vaginal
fistula associated to another tracts was detected. One
patients had necrotizing fascitis and one had a fistula
with horseshoeing abscess.
The most common surgical procedure was seton pla-
cement (one hundred and sixty-two patients (65%) for
the treatment of complex fistulae with involvement of
sphincter apparatus and fistulae in Crohn’s disease
patients (table 1).
In order to drain the sepsis, loose setons were placed
in 82 patients (table 2). While in 80 patients cutting
setons were tight progressively in outpatients clinic.
Loose seton was placed initially in 11 patients and fol-
lowed by mucosal advancement repair and Porcine dermal
collagen matrix injection.
Eighty-five patients (34%) underwent fistulotomy; this
p r o c e d u r ew a st h eo n l ys u r g e r yi n7 7( 3 1 % )p a t i e n t s ,m a i n l y
for intersphincteric and mid/low transphincteric fistulae.
Moreover, fistulotomy was performed as part of treatment
in eight patients with complex fistulae (8/80 = 10%).
Seventeen patients (6.8%) were submitted to mucosal
flap advancement for recurrent idiopathic high trans-
phincteric fistulae. Out of 17, seven had undergone one
surgical procedure for fistula while ten had more than 2
procedures.
Eighteen patients underwent LIFT (ligation of inter-
sphicteric tract). Six patients underwent permacol
injection
At EUA seven (2.8%) patients had diagnosis of recto-
vaginal fistula, and two of them presented more than 2
tracts. Five underwent loose seton placement followed
by advancement flap repair and two abscess drainage
plus seton.
The fistulae associated to ulcerative colitis were an
horseshoeing fistula, treated with wide drainage and
loose seton followed by mucosal advancement flap.
In our audit, out of 26 Crohn’s fistulae, 24 CD
patients with anal fistula underwent loose setons. This
was the only surgery in six cases. Seven patients had
seton plus fistulectomy; five had abscess drainage and
fistulotomy plus seton; five had abscess drainage plus
seton; one patient had fistulotomy and fistulectomy
plus seton. One had only fistulectomy, and the last CD
patient had fistulotomy plus fistulectomy. Out of 26
CD patients, The remnant two CD patients had
fistulotomy.
In one case, previously treated with mucosal flap for
high transphincteric fistulae, a colostomy was performed
because of a complete dehiscence of the flap.
Four cases were abscess drainage plus setons with or
without fistulotomy for sepsis. Three patients underwent
EUA-guided seton replacement. Two patients underwent
Table 1 Preoperative characteristics and treatment of
patients presenting with simple anal fistula
Second surgery Overall
NUMBER 77 (31%)
FISTULA CLASSIFICATION
Inter-sphincteric 57 (23%)
Mid/low trans-sphincteric 20 (8%)
PRINCIPAL SURGERY
Single staged fistulotomy 77 (31%) 8 85 (34%)
Postoperative Wexner score
Table 2 Preoperative characteristics and treatment of
patients presenting with complex anal fistula
2
nd surgery
NUMBER 162
FISTULA CLASSIFICATION
High Trans-sphincteric 122 (65%)
Extra-sphincteric 2 (0.8%)
Supra-sphincteric 2 (0.8%)
Recto-vaginal 7 (2.8%)
IBD 29 (11%)
PRINCIPAL SURGERY
Loose Seton 80 (32%) 11 ADF+permacol inj
17 ADF
18 LIFT
6 permacol injection
Cutting Seton 82 (33%) 8 (fistulotomy)
Postoperative Wexner score
MEAN FOLLOW-UP (MONTHS) 40 (range 6-74)
RECURRANCE RATE
INCONTINENCE 2.4%
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tulotomy was performed.
Three patients developed recurrence after seton place-
ment for high transphincteric fistula; they were sub-
mitted to mucosal flap advancement with completely
healing after seven weeks.
Two recurrences occurred after fistulotomy for inter-
sphincteric fistula(2/85 = 2.3%); one patient was treated
with fistulotomy, the other with cutting-seton placement.
Two patients submitted to mucosal flap advancement
for recurrent high transphincteric fistulas were retreated
with seton placement for anal sepsis. After three
months, when sepsis was completely solved, they under-
went a new mucosal advancement flap, with complete
healing after 8-10 weeks.
In two CD patients, surgery was necessary three times.
Two patients presenting with complex recto-vaginal fis-
tula (> 2 tracts) underwent first fistulectomy and loose-
setons, then two advancement flap plus Permacol injec-
tion. The other underwent firstly two abscess drainage
and setons, then proctectomy for severe perianal disease
with recto-urethral fistula.
Three cases of major faecal incontinence (1.3%) were
detected. Two females with major faecal incontinence
were observed during the follow up period; in a third
CD patient major faecal incontinence was present in
case of bowel movements higher than 4 daily.
In three cases (1.3%) minor incontinence was recorded
and successfully treated with biofeedback in 2 cases and
with permacol injection as bulking agent in one case.
The main treatment successfully eradicated the primary
fistula track, in non IBD fistulae, in 151/247 patients (61%)
and during the follow-up period all of whom remained
healed at the time of last review. Two male patients still
had a seton in situ controlling a residual primary fistula
track.
Discussion
Perianal fistulas have been a common troublesome
pathology.
According to the Parks classification, the rate of inter-
sphincteric fistulae reported in literature is 70%. Besides,
25% of fistulae are transphincteric, 5% are suprasphinc-
teric and 1% extrasphincteric [14,15].
Differently, in our audit, 8% of patients presented with
low transphincteric fistulae and about 23% of patients had
a intersphincteric fistula. Moreover, more than 62% were
complex fistulae and 2.8% were recto-vaginal, which
required careful assessment of the treatment strategy.
According to the literature, in our clinical experience,
surgical strategy was chosen according to type and com-
plexity of the fistula, sphincter involvement presence of
comorbidities and previous interventions.
Low transphincteric fistulas involve the lower third of
external anal sphincter apparatusand are generally treated
by fistulotomy with a high healing rate.
In our experience, eighty-five patients (34%) under-
went fistulotomy; this procedure was the only surgery in
77 (31%) patients, mainly for intersphincteric and mid/
low transphincteric fistulae without recurrences detected
in the follow up period.
Besides, recurrence rate after fistulotomy in literature is
noteworthy. In a recent retrospective trial on 624 patients,
Garcia Aguillar reported a recurrence rate of 8% [5].
Factors associated with recurrence included type and
extension of the fistula, lack of identification or lateral
location of the internal fistulous opening, previous fistula
surgery and the surgeon experience [5].
Differently, high fistulas with one or more tracts invol-
ving the upper external sphincter and levator ani remain
a surgical challenge for the colorectal surgeon.
In this case, transrectal ultrasound to identify the tract
and to define the anatomic relations with the muscles
and the contiguous organs can be helpful, especially in
conjunction with the use of peroxide, which delineates
the tract on the ultrasound image. Magnetic resonance
imaging (MRI) may also be helpful, especially in case of
suprasphincteric and extrasphincteric fistulas [16,17].
According to our preoperative protocol, transrectal
ultrasound and magnetic resonance imaging were not
routinely performed. Besides, digital examination was an
effective tool to assess fistula complexity
3 and compared
favourably with ultrasonography [18]. In this trial, ultra-
sonography and MRI were indicated mainly in the man-
agement of patients with Crohn’s disease, in case of high
fistulae with transphincteric, extrasphincteric, supras-
phincteric and/or multiple tracks, recto-vaginal fistulae,
often associated to proctitis.
Moreover, we didn’t perform routinely preoperative
anal manometry, advocated by some authors to prevent
incontinence after fistula surgery, but without reliable
results. Our thought is that manometry does not guar-
antee a protection against incontinente, but is more
important the knowledge of risk factors, like previous
fistula or perineal surgery, and findings during EUA.
In case of complex fistulas, the seton placement has
been advocated either loose, to control infection, or cut-
ting through the sphincter muscle gradually or as a bridge
between two separate partial fistulotomies [19,20]. In our
audit, the most common surgical procedure was the place-
ment of seton (65%), usually applied in case of complex
fistulae and Crohn’s patients and if loose followed by flap
procedure.
Regarding the comparison between seton and other
techniques, Tang et al in a large multicenter Indian
study (n = 503) comparing seton and fistulectomy,
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recurrence rate (4% vs 11%) [21]
.
Differently Zbar et al, compared conventional cutting
setons vs ‘internal anal sphincter preserving’ cutting seton
in 34 patients with trans-sphincteric fistulae and reported
no statistically significant differences in recurrence (11.1%
versus 6.25%), healing time (14 weeks versus 12 weeks)
and continence impairment (5.5% versus 12.5%) [22].
Transanal advancement flap has been advocated as an
effective treatment for trans-sphincteric fistulas passing
through the upper or middle third of the external anal
sphincter. In our cohort, 17 patients (6.8%) were sub-
mitted to mucosal flap advancement for recurrent idio-
pathic high transphincteric fistulae.
If we overview the literature, initially, the reported
healing rates of flap repair varied between 84 and 100
percent [23,24]. Subsequently, during the last decade,
several studies have revealed considerably higher recur-
rence rates.
Zimmerman et al, out of 87 patients, reported an heal-
ing rate of 67% after flap repair [25]. Similarly, Mitalas
et al reported 68% healing rate after treatment of 80
patients with transanal advancement flap repair [26].
In our audit, the majority of the fistulae encountered
were cryptoglandular (88%), nonetheless, the number of
fistulae in patients with Crohn’s disease was noteworthy
(10.5%).
Fistulas in Crohn’s disease are demanding to manage
and resistant to many traditional approaches. The
Crohn’s fistulas are thought to originate as a deep pene-
trating ulcer in the anorectum, plugged with fecal mate-
rial. Several conservative treatments have been described
in the literature to manage Crohn’s fistulas.
Medical therapy alone has been documented by sev-
eral series with closure rate up to 50% [27].
Surgery for Crohn’s fistulas has to be individualized to
the patient’s medical condition, the degree of activity of
proctocolitis, together with the location and type of fistula.
Complex fistulas in CD patients should be treated
conservatively to avoid the risk of incontinence. Seton
placement is the gold standard in these cases and this
helps the fistula to heal and allows continued drainage
without abscess.
Only 6 recurrences were observed in patients without
inflammatory bowel disease in our trial. Few reports of
long-term follow-up and recurrence exist. In line with
our results, Malouf [19] reported a 4% recurrence rate
at 14 moths’ follow up. A recurrence rate of 6.3% has
been reported at a follow up of over 3 years by Vasilesky
[28].
Faecal incontinence remains a problem after fistula
surgery. Reported incontinence rates vary considerably
f r o m0t o4 0 %l a r g e l yb e c a u s eo fl a c ko fs t a n d a r d i z a -
tion and variable follow-up [19]. In the recent study of
Garcia Aguillar [5], out of 624 patients, 45% com-
plained of some degree of postoperative continence.
Incontinence was associated with complex fistulas,
type of surgery and previous fistula surgery. Besides in
line with Malouf et al, in our audit, three cases of
major faecal incontinence (1.2%) were detected and in
three cases (1.2%) minor incontinence was recorded
and successfully treated with biofeedback in 2 cases
and with Permacol injection as bulking agent in one
case.
Conclusions
In summary, a high proportion of complex fistulas was
seen in the present audit compared with previous studies.
Despite this a satisfactory outcome was achieved in the
vast majority with a relatively low rate of incontinence.
Caution was used when dealing with anal fistula Crohn’s
disease, frequently complex and requiring several treat-
ments and often treated with loose setons. New technolo-
gies provide promising alternatives to traditional
methods of management particulary in case of complex
fistulas. High-quality randomized control trials to evalu-
ate the different surgical and non surgical treatment
options are warranted.
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